386 related articles for article (PubMed ID: 33001241)
1. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
[TBL] [Abstract][Full Text] [Related]
5. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
Hardee ME; Raza S; Becker SJ; Jozsef G; Lymberis SC; Hochman T; Goldberg JD; DeWyngaert KJ; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e415-23. PubMed ID: 22019349
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
8. Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
Hörner-Rieber J; Forster T; Hommertgen A; Haefner MF; Arians N; König L; Harrabi SB; Schlampp I; Weykamp F; Lischalk JW; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Hof H; Krug D; Debus J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1311-1324. PubMed ID: 33321192
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
Jin K; Luo J; Yu X; Guo X
Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
[TBL] [Abstract][Full Text] [Related]
18. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Hong Z; Yang Z; Mei X; Li P; Bao C; Wang Z; Cai X; Ming X; Wang W; Guo X; Yu X; Zhang Q
Radiat Oncol; 2023 Mar; 18(1):56. PubMed ID: 36959653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]